11/14/2024 | Press release | Distributed by Public on 11/14/2024 10:30
Seattle, WA, November 14, 2024 / EINPresswire.com /- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced that its STARgraft arteriovenous graft - designed to provide a safer and more reliable means of bloodstream access for kidney failure patients needing dialysis - has been granted Breakthrough Device designation by the FDA.
Read more.